Back

Long-term prognostic impact of pulmonary vascular resistance in patients with rheumatic mitral stenosis undergoing percutaneous mitral balloon valvuloplasty

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Mitral stenosis: from diagnosis to treatment Invasive Haemodynamic Assessment ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Daniella Cian Nazzetta

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

7 More presentations in this session

Presentation thumbnail
Determinants of exercise-induced pulmonary hypertension in rheumatic mitral stenosis: a study with exercise stress and speckle tracking echocardiography
Doctor S. Lee (Seoul, KR)
Abstract Slides
Presentation thumbnail
Percutaneous valve commissurotomy in mitral stenosis patients: a 20 years follow-up
Doctor R. Alves Pinto (Porto, PT)
Abstract Slides
Presentation thumbnail
Prognostic significance of mean transmitral pressure gradient in degenerative non-rheumatic mitral valve: insights from a vast echocardiographic database
Doctor E. Massalha (Ramat Gan, IL)
Abstract Slides
Presentation thumbnail
Identification of distinct subgroups in moderately severe rheumatic mitral stenosis using data-driven phenotyping of longitudinal hemodynamic progression
Mr K. Ko (Seoul, KR)
Abstract Slides
Presentation thumbnail
Severe rheumatic mitral stenosis - analysis of clinical and echocardiographic very long-term outcomes after percutaneous mitral balloon valvuloplasty
Doctor J. Presume (Lisbon, PT)
Abstract Slides

Access the full session

Session thumbnail
Mitral stenosis: from diagnosis to treatment

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources